An Italian Multicenter Retrospective Observational Study to Assess the Clinical Characteristics and the Outcome of Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma Treated With Polatuzumab Vedotin Plus Rituximab (± Bendamustine) Under Named Patient Programme

NCT06734078 · clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
100
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

IRCCS Azienda Ospedaliero-Universitaria di Bologna